期刊文献+

大肠癌的规范化手术治疗+基础化疗 被引量:2

暂未订购
导出
摘要 目的:观察应用大肠癌的规范化手术治疗+基础化疗的效果。方法:选择大肠癌患者40例,都采用采用规范化手术治疗+基础化疗。结果:经过治疗后无CR病例,有效率为52.5%,随访3个月的死亡率为0。不良反应发生率为37.5%,均经对症治疗缓解。随着治疗时间的推荐,CEA与CA19-9值都明显降低,不同时间点对比差异明显(P<0.05)。结论:大肠癌是最常见的恶性肿瘤之一,规范化手术治疗+基础化疗在一定程度上提高生存率,减轻不良反应。
作者 王和彪
机构地区 镇坪县医院
出处 《内蒙古中医药》 2013年第3期15-16,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献12

  • 1[1]Wolmark N, Rockette H, Mamounas E, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Duke'B and C carcinoma of the colon: results from the National Surgical Adjuvant Breast and Bowel Project C-04[J]. J Clin Oncol, 1999, 17(11): 3553~3559
  • 2[2]Mamounas E, Wieand S, Wolmark N, et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes'B versus Dukes'C colon cancer: results from four National surgical Adjuvant Breast and Bowel Project adjuvant studies (C01, C-02, C-03 and C-04)[J]. J Clin Oncol, 1999, 17(5):1349~1355
  • 3[3]Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2Colon Cancer. International Multicentre Pooled Analysis of B2Colon Cancer Trials (IMPACT B2) Investigators [J]. J Clin Oncol, 1999, 17(5): 1356~1363
  • 4[4]QUASAR Collaborative Group: Comparison of fluorouracil with additional levamisole. High-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: A randomized trail[J]. Lancet, 2000, 355(9215): 1588~1596
  • 5[5]Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival [J]. Dis Colon Rectum, 2002, 45(7): 895~903
  • 6[6]Fong Y. Surgical therapy of hepatic colorectal metastasis [J].CA Cancer J Glin, 1999, 49(4): 231~255
  • 7[7]Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer [J]. N Engl J Med, 1999, 341 (27):2039 ~2048
  • 8[8]Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fiuorouracil and leucovorin for metastatic colorectal cancer [J]. N Engl J Med, 2000, 343(13): 905~914
  • 9[9]Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fiuorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial[J]. Lancet, 2000, 355(9209): 1041~1047
  • 10[10]Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲstudy[J]. J Clin Oncol, 2001, 19(8): 2282~2292

共引文献53

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部